ReP USP - Resultado da busca

Artigo de periodico
Appetite effects of prefrontal stimulation depend on COMT Val158Met polymorphism: a randomized clinical trial (2019)
Fassini, Priscila Giacomo ; Das, Sai Krupa; Suen, Vivian Marques Miguel; Magerowski, Greta; Marchini, Julio Sergio ; Silva Junior, Wilson Araújo da ; Changyu, Shen; Alonso-Alonso, Miguel
Source: Appetite. Unidade: FMRP
Subjects: POLIMORFISMO, NEUROTRANSMISSORES, APETITE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FASSINI, Priscila Giacomo et al. Appetite effects of prefrontal stimulation depend on COMT Val158Met polymorphism: a randomized clinical trial. Appetite, v. 140, p. 142-150, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.appet.2019.05.015. Acesso em: 19 nov. 2024.
APA
Fassini, P. G., Das, S. K., Suen, V. M. M., Magerowski, G., Marchini, J. S., Silva Junior, W. A. da, et al. (2019). Appetite effects of prefrontal stimulation depend on COMT Val158Met polymorphism: a randomized clinical trial. Appetite, 140, 142-150. doi:10.1016/j.appet.2019.05.015
NLM
Fassini PG, Das SK, Suen VMM, Magerowski G, Marchini JS, Silva Junior WA da, Changyu S, Alonso-Alonso M. Appetite effects of prefrontal stimulation depend on COMT Val158Met polymorphism: a randomized clinical trial [Internet]. Appetite. 2019 ; 140 142-150.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.appet.2019.05.015
Vancouver
Fassini PG, Das SK, Suen VMM, Magerowski G, Marchini JS, Silva Junior WA da, Changyu S, Alonso-Alonso M. Appetite effects of prefrontal stimulation depend on COMT Val158Met polymorphism: a randomized clinical trial [Internet]. Appetite. 2019 ; 140 142-150.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.appet.2019.05.015
Artigo de periodico
Insulin/IGF1 signalling mediates the effects of β2- adrenergic agonist on muscle proteostasis and growth (2019)
Gonçalves, Dawit Albieiro Pinheiro ; Silveira, Wilian de Assis ; Manfredi, Leandro Henrique ; Graça, Flávia A.; Armani, Andrea; Bertaggia, Enrico; O´Neill, Brian T.; Silva, Natalia Lautherbach Ennes da ; Machado, Juliano; Nogara, Leonardo; Pereira, Marcelo G.; Arcidiacono, Diletta; Realdon, Stefano; Kahn, C. Ronald; Sandri, Marco ; Kettelhut, Isis Carmo ; Navegantes, Luiz Carlos Carvalho
Source: Journal of Cachexia, Sarcopenia and Muscle. Unidade: FMRP
Subjects: INSULINA, METABOLISMO DE PROTEÍNA, MÚSCULO ESQUELÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONÇALVES, Dawit Albieiro Pinheiro et al. Insulin/IGF1 signalling mediates the effects of β2- adrenergic agonist on muscle proteostasis and growth. Journal of Cachexia, Sarcopenia and Muscle, v. 10, n. 2, p. 455-475, 2019Tradução . . Disponível em: https://doi.org/10.1002/jcsm.12395. Acesso em: 19 nov. 2024.
APA
Gonçalves, D. A. P., Silveira, W. de A., Manfredi, L. H., Graça, F. A., Armani, A., Bertaggia, E., et al. (2019). Insulin/IGF1 signalling mediates the effects of β2- adrenergic agonist on muscle proteostasis and growth. Journal of Cachexia, Sarcopenia and Muscle, 10( 2), 455-475. doi:10.1002/jcsm.12395
NLM
Gonçalves DAP, Silveira W de A, Manfredi LH, Graça FA, Armani A, Bertaggia E, O´Neill BT, Silva NLE da, Machado J, Nogara L, Pereira MG, Arcidiacono D, Realdon S, Kahn CR, Sandri M, Kettelhut IC, Navegantes LCC. Insulin/IGF1 signalling mediates the effects of β2- adrenergic agonist on muscle proteostasis and growth [Internet]. Journal of Cachexia, Sarcopenia and Muscle. 2019 ; 10( 2): 455-475.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1002/jcsm.12395
Vancouver
Gonçalves DAP, Silveira W de A, Manfredi LH, Graça FA, Armani A, Bertaggia E, O´Neill BT, Silva NLE da, Machado J, Nogara L, Pereira MG, Arcidiacono D, Realdon S, Kahn CR, Sandri M, Kettelhut IC, Navegantes LCC. Insulin/IGF1 signalling mediates the effects of β2- adrenergic agonist on muscle proteostasis and growth [Internet]. Journal of Cachexia, Sarcopenia and Muscle. 2019 ; 10( 2): 455-475.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1002/jcsm.12395
Artigo de periodico
Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis (2019)
Arroyo, Gianfranco; Bustos, Javier A.; Lescano, Andres G.; Gonzales, Isidro; Saavedra, Herbert; Rodriguez, Silvia; Pretell, E. Javier; Bonato, Pierina Sueli; Lanchote, Vera Lucia ; Takayanagui, Osvaldo Massaiti ; Horton, John; Gonzalez, Armando E.; Gilman, Robert H.; Garcia, Hector H.
Source: Clinical Infectious Diseases. Unidades: FCFRP, FMRP
Subjects: NEUROCISTICERCOSE, ANTIPARASITÁRIOS, ANTI-HELMÍNTICOS, CISTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARROYO, Gianfranco et al. Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis. Clinical Infectious Diseases, v. 69, n. 11, p. 1996-2002, 2019Tradução . . Disponível em: https://doi.org/10.1093/cid/ciz085. Acesso em: 19 nov. 2024.
APA
Arroyo, G., Bustos, J. A., Lescano, A. G., Gonzales, I., Saavedra, H., Rodriguez, S., et al. (2019). Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis. Clinical Infectious Diseases, 69( 11), 1996-2002. doi:10.1093/cid/ciz085
NLM
Arroyo G, Bustos JA, Lescano AG, Gonzales I, Saavedra H, Rodriguez S, Pretell EJ, Bonato PS, Lanchote VL, Takayanagui OM, Horton J, Gonzalez AE, Gilman RH, Garcia HH. Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis [Internet]. Clinical Infectious Diseases. 2019 ; 69( 11): 1996-2002.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1093/cid/ciz085
Vancouver
Arroyo G, Bustos JA, Lescano AG, Gonzales I, Saavedra H, Rodriguez S, Pretell EJ, Bonato PS, Lanchote VL, Takayanagui OM, Horton J, Gonzalez AE, Gilman RH, Garcia HH. Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis [Internet]. Clinical Infectious Diseases. 2019 ; 69( 11): 1996-2002.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1093/cid/ciz085
Artigo de periodico
Equilin displays similar endothelium-independent vasodilator potential to 17β-estradiol regardless of lower potential to inhibit calcium entry (2019)
Filgueira, Fernando Paranaiba; Lobato, Núbia de Souza; Nascimento, Denise L.; Ceravolo, Graziela Scalianti; Giachini, Fernanda R. C.; Lima, Victor V.; Dantas, Ana Paula; Fortes, Zuleica Bruno; Webb, R. Clinton; Tostes, Rita de Cássia Aleixo ; Carvalho, Maria Helena Catelli de
Source: Steroids. Unidades: ICB, FMRP
Subjects: ESTRADIOL, ARTÉRIAS, VASODILATAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FILGUEIRA, Fernando Paranaiba et al. Equilin displays similar endothelium-independent vasodilator potential to 17β-estradiol regardless of lower potential to inhibit calcium entry. Steroids, v. 141, p. 46-54, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.steroids.2018.11.006. Acesso em: 19 nov. 2024.
APA
Filgueira, F. P., Lobato, N. de S., Nascimento, D. L., Ceravolo, G. S., Giachini, F. R. C., Lima, V. V., et al. (2019). Equilin displays similar endothelium-independent vasodilator potential to 17β-estradiol regardless of lower potential to inhibit calcium entry. Steroids, 141, 46-54. doi:10.1016/j.steroids.2018.11.006
NLM
Filgueira FP, Lobato N de S, Nascimento DL, Ceravolo GS, Giachini FRC, Lima VV, Dantas AP, Fortes ZB, Webb RC, Tostes R de CA, Carvalho MHC de. Equilin displays similar endothelium-independent vasodilator potential to 17β-estradiol regardless of lower potential to inhibit calcium entry [Internet]. Steroids. 2019 ; 141 46-54.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.steroids.2018.11.006
Vancouver
Filgueira FP, Lobato N de S, Nascimento DL, Ceravolo GS, Giachini FRC, Lima VV, Dantas AP, Fortes ZB, Webb RC, Tostes R de CA, Carvalho MHC de. Equilin displays similar endothelium-independent vasodilator potential to 17β-estradiol regardless of lower potential to inhibit calcium entry [Internet]. Steroids. 2019 ; 141 46-54.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.steroids.2018.11.006
Artigo de periodico
Design and characterization of crotamine-functionalized gold nanoparticles (2018)
Karpel, Richard L.; Liberato, Michelle da Silva; Campeiro, Joana D.; Bergeon, Lorna; Szychowski, Brian; Butler, Andrew; Marino, Giovanni; Cusic, Joelle F.; Oliveira, Lilian Caroline Gonçalves de; Oliveira, Eduardo Brandt de; Farias, Marcelo Alexandre de; Portugal, Rodrigo Villares; Alves, Wendel Andrade; Daniel, Marie-Christine; Hayashi, Mirian A. F.
Source: Colloids and Surfaces B: Biointerfaces. Unidade: FMRP
Subjects: TOXINAS, COBRAS, POLIPEPTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KARPEL, Richard L. et al. Design and characterization of crotamine-functionalized gold nanoparticles. Colloids and Surfaces B: Biointerfaces, v. 163, p. 1-8, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfb.2017.12.013. Acesso em: 19 nov. 2024.
APA
Karpel, R. L., Liberato, M. da S., Campeiro, J. D., Bergeon, L., Szychowski, B., Butler, A., et al. (2018). Design and characterization of crotamine-functionalized gold nanoparticles. Colloids and Surfaces B: Biointerfaces, 163, 1-8. doi:10.1016/j.colsurfb.2017.12.013
NLM
Karpel RL, Liberato M da S, Campeiro JD, Bergeon L, Szychowski B, Butler A, Marino G, Cusic JF, Oliveira LCG de, Oliveira EB de, Farias MA de, Portugal RV, Alves WA, Daniel M-C, Hayashi MAF. Design and characterization of crotamine-functionalized gold nanoparticles [Internet]. Colloids and Surfaces B: Biointerfaces. 2018 ; 163 1-8.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.colsurfb.2017.12.013
Vancouver
Karpel RL, Liberato M da S, Campeiro JD, Bergeon L, Szychowski B, Butler A, Marino G, Cusic JF, Oliveira LCG de, Oliveira EB de, Farias MA de, Portugal RV, Alves WA, Daniel M-C, Hayashi MAF. Design and characterization of crotamine-functionalized gold nanoparticles [Internet]. Colloids and Surfaces B: Biointerfaces. 2018 ; 163 1-8.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.colsurfb.2017.12.013
Artigo de periodico
Pyrazines from bacteria and ants: convergent chemistry within an ecological niche (2018)
Silva-Junior, Eduardo A.; Ruzzini, Antonio C.; Paludo, Camila R.; Nascimento, Fábio Santos do; Currie, Cameron R.; Clardy, Jon; Pupo, Mônica Tallarico
Source: Scientific Reports. Unidades: FFCLRP, FCFRP
Subjects: FORMIGAS, AMINOÁCIDOS, PRODUTOS NATURAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA-JUNIOR, Eduardo A. et al. Pyrazines from bacteria and ants: convergent chemistry within an ecological niche. Scientific Reports, v. 8, n. 1, 2018Tradução . . Disponível em: https://doi.org/10.1038/s41598-018-20953-6. Acesso em: 19 nov. 2024.
APA
Silva-Junior, E. A., Ruzzini, A. C., Paludo, C. R., Nascimento, F. S. do, Currie, C. R., Clardy, J., & Pupo, M. T. (2018). Pyrazines from bacteria and ants: convergent chemistry within an ecological niche. Scientific Reports, 8( 1). doi:10.1038/s41598-018-20953-6
NLM
Silva-Junior EA, Ruzzini AC, Paludo CR, Nascimento FS do, Currie CR, Clardy J, Pupo MT. Pyrazines from bacteria and ants: convergent chemistry within an ecological niche [Internet]. Scientific Reports. 2018 ; 8( 1):[citado 2024 nov. 19 ] Available from: https://doi.org/10.1038/s41598-018-20953-6
Vancouver
Silva-Junior EA, Ruzzini AC, Paludo CR, Nascimento FS do, Currie CR, Clardy J, Pupo MT. Pyrazines from bacteria and ants: convergent chemistry within an ecological niche [Internet]. Scientific Reports. 2018 ; 8( 1):[citado 2024 nov. 19 ] Available from: https://doi.org/10.1038/s41598-018-20953-6
Artigo de periodico
Oncogenic signaling pathways in the cancer genome atlas (2018)
Sanchez-Vega, Francisco; Noushmehr, Houtan; Carlotti Júnior, Carlos Gilberto; Santos, José Sebastião dos; Kemp, Rafael; Sankarankutty, Ajith Kumar; Tirapelli, Daniela Pretti da Cunha
Source: Cell. Unidade: FMRP
Subjects: GENÔMICA, NEOPLASIAS, ONCOLOGIA, TERAPÊUTICA, CICLO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANCHEZ-VEGA, Francisco et al. Oncogenic signaling pathways in the cancer genome atlas. Cell, v. 173, n. 2, p. 321-337.e1-e4, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.cell.2018.03.035. Acesso em: 19 nov. 2024.
APA
Sanchez-Vega, F., Noushmehr, H., Carlotti Júnior, C. G., Santos, J. S. dos, Kemp, R., Sankarankutty, A. K., & Tirapelli, D. P. da C. (2018). Oncogenic signaling pathways in the cancer genome atlas. Cell, 173( 2), 321-337.e1-e4. doi:10.1016/j.cell.2018.03.035
NLM
Sanchez-Vega F, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. Oncogenic signaling pathways in the cancer genome atlas [Internet]. Cell. 2018 ; 173( 2): 321-337.e1-e4.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.cell.2018.03.035
Vancouver
Sanchez-Vega F, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. Oncogenic signaling pathways in the cancer genome atlas [Internet]. Cell. 2018 ; 173( 2): 321-337.e1-e4.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.cell.2018.03.035
Artigo de periodico
Comprehensive characterization of cancer driver genes and mutations (2018)
Bailey, Matthew H.; Noushmehr, Houtan; Carlotti Júnior, Carlos Gilberto; Santos, José Sebastião dos; Kemp, Rafael; Sankarankutty, Ajith Kumar; Tirapelli, Daniela Pretti da Cunha
Source: Cell. Unidade: FMRP
Subjects: NEOPLASIAS, MUTAÇÃO, GENOMAS, BIOINFORMÁTICA, ENTROPIA, ALGORITMOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BAILEY, Matthew H. et al. Comprehensive characterization of cancer driver genes and mutations. Cell, v. 173, n. 2, p. 371-385.e1-e9, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.cell.2018.02.060. Acesso em: 19 nov. 2024.
APA
Bailey, M. H., Noushmehr, H., Carlotti Júnior, C. G., Santos, J. S. dos, Kemp, R., Sankarankutty, A. K., & Tirapelli, D. P. da C. (2018). Comprehensive characterization of cancer driver genes and mutations. Cell, 173( 2), 371-385.e1-e9. doi:10.1016/j.cell.2018.02.060
NLM
Bailey MH, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. Comprehensive characterization of cancer driver genes and mutations [Internet]. Cell. 2018 ; 173( 2): 371-385.e1-e9.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.cell.2018.02.060
Vancouver
Bailey MH, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. Comprehensive characterization of cancer driver genes and mutations [Internet]. Cell. 2018 ; 173( 2): 371-385.e1-e9.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.cell.2018.02.060
Artigo de periodico
Propagating annotations of molecular networks using in silico fragmentation (2018)
Silva, Ricardo R. da; Wang, Mingxun; Nothias, Louis-Félix; van der Hooft, Justin J. J.; Caraballo-Rodríguez, Andrés Mauricio; Fox, Evan; Balunas, Marcy J.; Klassen, Jonathan L.; Lopes, Norberto Peporine; Dorrestein, Pieter C.
Source: PLOS Computational Biology. Unidade: FCFRP
Subjects: FORMIGAS, BIOINFORMÁTICA, FUNGOS, QUÍMICA, SIMULAÇÃO, ESPECTROSCOPIA DE MASSA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Ricardo R. da et al. Propagating annotations of molecular networks using in silico fragmentation. PLOS Computational Biology, v. 14, n. 4, 2018Tradução . . Disponível em: https://doi.org/10.1371/journal.pcbi.1006089. Acesso em: 19 nov. 2024.
APA
Silva, R. R. da, Wang, M., Nothias, L. -F., van der Hooft, J. J. J., Caraballo-Rodríguez, A. M., Fox, E., et al. (2018). Propagating annotations of molecular networks using in silico fragmentation. PLOS Computational Biology, 14( 4). doi:10.1371/journal.pcbi.1006089
NLM
Silva RR da, Wang M, Nothias L-F, van der Hooft JJJ, Caraballo-Rodríguez AM, Fox E, Balunas MJ, Klassen JL, Lopes NP, Dorrestein PC. Propagating annotations of molecular networks using in silico fragmentation [Internet]. PLOS Computational Biology. 2018 ; 14( 4):[citado 2024 nov. 19 ] Available from: https://doi.org/10.1371/journal.pcbi.1006089
Vancouver
Silva RR da, Wang M, Nothias L-F, van der Hooft JJJ, Caraballo-Rodríguez AM, Fox E, Balunas MJ, Klassen JL, Lopes NP, Dorrestein PC. Propagating annotations of molecular networks using in silico fragmentation [Internet]. PLOS Computational Biology. 2018 ; 14( 4):[citado 2024 nov. 19 ] Available from: https://doi.org/10.1371/journal.pcbi.1006089
Artigo de periodico
Genomic, pathway petwork, and immunologic features distinguishing squamous carcinomas (2018)
Campbell, Joshua D.; Noushmehr, Houtan; Carlotti Júnior, Carlos Gilberto; Santos, José Sebastião dos; Kemp, Rafael; Sankarankutty, Ajith Kumar; Tirapelli, Daniela Pretti da Cunha
Source: Cell Reports. Unidade: FMRP
Subjects: GENÔMICA, CARCINOMA DE CÉLULAS ESCAMOSAS, PROTEÔMICA, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPBELL, Joshua D. et al. Genomic, pathway petwork, and immunologic features distinguishing squamous carcinomas. Cell Reports, v. 23, n. 1, p. 194-212.e1-e6, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.celrep.2018.03.063. Acesso em: 19 nov. 2024.
APA
Campbell, J. D., Noushmehr, H., Carlotti Júnior, C. G., Santos, J. S. dos, Kemp, R., Sankarankutty, A. K., & Tirapelli, D. P. da C. (2018). Genomic, pathway petwork, and immunologic features distinguishing squamous carcinomas. Cell Reports, 23( 1), 194-212.e1-e6. doi:10.1016/j.celrep.2018.03.063
NLM
Campbell JD, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. Genomic, pathway petwork, and immunologic features distinguishing squamous carcinomas [Internet]. Cell Reports. 2018 ; 23( 1): 194-212.e1-e6.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.celrep.2018.03.063
Vancouver
Campbell JD, Noushmehr H, Carlotti Júnior CG, Santos JS dos, Kemp R, Sankarankutty AK, Tirapelli DP da C. Genomic, pathway petwork, and immunologic features distinguishing squamous carcinomas [Internet]. Cell Reports. 2018 ; 23( 1): 194-212.e1-e6.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.celrep.2018.03.063
Artigo de periodico
Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia (2018)
Gomes, Felipe Villela ; Edelson, Jessica R.; Volk, David W.; Grace, Anthony A.
Source: Schizophrenia Research. Unidade: FMRP
Subjects: CANABINOIDES, TRANSTORNOS PSICÓTICOS, ESQUIZOFRENIA, CÉREBRO, CRESCIMENTO E DESENVOLVIMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Felipe Villela et al. Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia. Schizophrenia Research, v. 201, p. 254-260, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.schres.2018.04.030. Acesso em: 19 nov. 2024.
APA
Gomes, F. V., Edelson, J. R., Volk, D. W., & Grace, A. A. (2018). Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia. Schizophrenia Research, 201, 254-260. doi:10.1016/j.schres.2018.04.030
NLM
Gomes FV, Edelson JR, Volk DW, Grace AA. Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia [Internet]. Schizophrenia Research. 2018 ; 201 254-260.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.schres.2018.04.030
Vancouver
Gomes FV, Edelson JR, Volk DW, Grace AA. Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia [Internet]. Schizophrenia Research. 2018 ; 201 254-260.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.schres.2018.04.030

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration